Streamlining Your NCA Workflow
准备递交的 PK 分析面临着许多数据和合规方面的挑战。To work efficiently,…
Danielle Pillsbury2024 年 1 月 18 日
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database
To assess real-world treatment patterns in patients diagnosed with hormone receptor positive (HR+), human epidermal…
Jim Gallagher2024 年 1 月 17 日
Higher Standards: Achieving Cleaner Data, Faster, from Protocol to Submission
Join our webinar to explore best practices for harnessing the power of standards, without a…
Danielle Pillsbury2024 年 1 月 16 日
Real-world application of PBPK in drug discovery
The utility of PBPK models in support of drug development has been well documented. During…
Jim Gallagher2024 年 1 月 11 日
Industrializing Quantitative Systems Pharmacology (QSP): Why now and how.
What does it take to industrialize QSP? What is the right mix of technology and…
Danielle Pillsbury2024 年 1 月 9 日
MedCity News | How the IRA Has Created a New Environment for Biosimilars
By Maximillian Vargas and Caitlin Verrilli As IRA provisions are activated, the law’s impact on…
Jim Gallagher2024 年 1 月 5 日
Clinical Research News | Trendspotting: What’s Coming for Clinical Trials and Research in 2024
By Clinical Research Team We spoke with leaders and experts in the Clinical Research community…
Jim Gallagher2024 年 1 月 5 日
Bio-IT World | Trendspotting: What’s Coming for Biotech in 2024
By Bio-IT World Team To kick off the New Year, we spoke with leaders and…
Jim Gallagher2024 年 1 月 5 日
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations
This mini-review provides a concise and comprehensive overview of the pregnancy PBPK field and identify…
Jim Gallagher2024 年 1 月 3 日
